Search research articles
Contact Us
Filters
Showing results (11-20 of 94) with videos related to
Page
of 10
Sort By:
The Prostate
|
March 10, 2001
Characteristics of normal prostate vascular anatomy as displayed by power Doppler
A K Leventis, S F Shariat, T Utsunomiya, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
October 17, 2008
Screening for bladder cancer using urine-based tumor markers
R S Svatek, Y Lotan, P I Karakiewizc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
August 27, 2014
[Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art review for the yearly scientific report of the French National Association of Urology]
Y Neuzillet, P Colin, V Phé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 10, 2014
[Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology]
P Colin, J Irani, S J Drouin, et al.
Der Urologe. Ausg. A
|
March 21, 2013
[Confidence intervals and p-values in urology: interpretation and misinterpretation]
M Rink, L A Kluth, S F Shariat, et al.
Der Urologe. Ausg. A
|
May 25, 2013
[Kaplan-Meier analysis in urological practice]
M Rink, L A Kluth, S F Shariat, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
October 17, 2008
Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer
M P Herman, R S Svatek, Y Lotan, et al.
Der Urologe. Ausg. A
|
March 28, 2013
[Use and interpretation of the number needed to treat in urological practice]
L A Kluth, M Rink, S F Shariat, et al.
Der Urologe. Ausg. A
|
May 29, 2013
[Randomized controlled trials terminated prematurely: beneficial therapy effects]
L A Kluth, M Rink, S A Ahyai, et al.
ESMO Open
|
July 4, 2021
Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
I Resch, A Bruchbacher, J Franke, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 94) with videos related to
Sort By:
Page
of 10
The Prostate
|
March 10, 2001
Characteristics of normal prostate vascular anatomy as displayed by power Doppler
A K Leventis, S F Shariat, T Utsunomiya, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
October 17, 2008
Screening for bladder cancer using urine-based tumor markers
R S Svatek, Y Lotan, P I Karakiewizc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
August 27, 2014
[Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art review for the yearly scientific report of the French National Association of Urology]
Y Neuzillet, P Colin, V Phé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 10, 2014
[Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology]
P Colin, J Irani, S J Drouin, et al.
Der Urologe. Ausg. A
|
March 21, 2013
[Confidence intervals and p-values in urology: interpretation and misinterpretation]
M Rink, L A Kluth, S F Shariat, et al.
Der Urologe. Ausg. A
|
May 25, 2013
[Kaplan-Meier analysis in urological practice]
M Rink, L A Kluth, S F Shariat, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
October 17, 2008
Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer
M P Herman, R S Svatek, Y Lotan, et al.
Der Urologe. Ausg. A
|
March 28, 2013
[Use and interpretation of the number needed to treat in urological practice]
L A Kluth, M Rink, S F Shariat, et al.
Der Urologe. Ausg. A
|
May 29, 2013
[Randomized controlled trials terminated prematurely: beneficial therapy effects]
L A Kluth, M Rink, S A Ahyai, et al.
ESMO Open
|
July 4, 2021
Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
I Resch, A Bruchbacher, J Franke, et al.
Page
of 10